> ## Content Index > Fetch the complete content index at: https://www.moatmarginresearch.com/llms.txt > Use this file to discover other available public pages before exploring further. # Daily Filing Digest — Monday, 21 Sep 2026 - URL: https://www.moatmarginresearch.com/daily-filing-digest-2026-09-21/ - Published: 2026-09-22T03:04:37.000Z - Updated: 2026-09-22T03:04:37.000Z - Description: Dilip Buildcon's Rs 6,829cr solar divestment, a Rs 600cr QIP, a radiology exit, and one small-cap's qualified audit opinion buried past its own investor deck. - Author: A K Karthikeyan - Tags: Daily Filing Digest **Dilip Buildcon signed away its under-construction solar portfolio at an enterprise value of about ₹6,829 crore, continuing its asset-light pivot, on a day that also carried a ₹600 crore QIP, a radiology-business exit, and one small-cap's results filing whose 9.2x revenue growth arrived beside a qualified audit opinion on both its standalone and consolidated books.** ## The one to read first **Elitecon International** reported consolidated revenue up 9.2x and profit after tax up 2.7x for FY26 — and its own auditor qualified both the standalone and consolidated opinions, citing a disputed ₹64 crore loan claim that has triggered an insolvency petition against the company, a SEBI forensic-audit order into its own shareholding pattern, and roughly ₹2,431 crore of the consolidated revenue sitting in three subsidiaries whose accounts the auditor could not verify were converted to the right accounting standard. Full read: [Elitecon's Revenue Grew 9.2x. Its Own Auditor Couldn't Verify Half of It.](https://www.moatmarginresearch.com/elitecon-qualified-opinion-revenue-growth/) ## Deals and divestments - **Dilip Buildcon** [executed definitive agreements](https://nsearchives.nseindia.com/corporate/DBL%5F21092026144957%5FPress%5Frelease.pdf) with Alpha Alternatives to divest its stake in ten solar SPVs held through DBL Renewable, an approximately 1,363 MW under-construction portfolio with an estimated project cost of ₹6,263 crore. DBRL and Alpha will fund the equity portion 51:49 during construction, after which DBL's remaining 51% will also be acquired by Alpha-led funds; the whole transaction is valued at an enterprise value of approximately ₹6,829 crore. - **Thyrocare Technologies** approved the [sale of its entire stake in Nueclear Healthcare](https://nsearchives.nseindia.com/corporate/THYROCARE%5F21092026150858%5FOutcome%5FIntimation-BM.pdf) (its radiology business) to Trovera Healthcare for approximately ₹141.4 crore — ₹59.5 crore in convertible preference shares and approximately ₹81.9 crore in cash, subject to a working-capital adjustment — exiting radiology to focus capital on pathology. - **Samvardhana Motherson International**'s subsidiary Samvardhana Motherson Adsys Tech [approved buying 50.1%](https://nsearchives.nseindia.com/corporate/MOTHERSON%5F21092026101734%5FDisclsoure%5F21092026.pdf) of Rotary Connectors Private Limited, making it an indirect subsidiary of the group; the filing does not state a consideration. - **Zodiac Energy** [completed the acquisition](https://nsearchives.nseindia.com/corporate/ZODIAC%5F21092026174950%5FReg%5F30%5FZenwatt%5FAcquisition%5F.pdf) of a 63.5% stake in Zenwatt Clean Energy for ₹1.14 crore, continuing a strategic investment first disclosed on 9 February. - **Kapil Raj Finance**'s board approved [acquiring 90% of Henyo Pack Limited](https://www.bseindia.com/xml-data/corpfiling/AttachLive/8c0257d1-966e-4be4-8ee0-f3a7a2b92da5.pdf) via a share swap — up to 26,54,87,700 shares at ₹2.24 each to Henyo's shareholders — alongside a separate cash preferential issue, an authorised-capital increase and a proposed name change. A same-day public announcement of an open offer by the company's promoters could not be independently verified (the filing did not extract as readable text) and is not otherwise used here. ## Capital raises - **Neogen Chemicals** [raised about ₹600 crore](https://nsearchives.nseindia.com/corporate/NEOGEN%5F21092026160124%5FPRfinal.pdf) via its first-ever Qualified Institutions Placement, allotting 26,60,753 equity shares at ₹2,255 each; the company's press release states the issue was oversubscribed 6.5 times. - **TD Power Systems** [allotted 12,50,000 equity shares](https://nsearchives.nseindia.com/corporate/TDPOWERSYS%5F21092026105154%5FIntimation%5FLetter-Sg123456789.pdf) at ₹600 each on a preferential basis to two allottees, aggregating ₹75 crore, per an EGM resolution dated 10 September. ## Order wins - **GK Energy** [received a Letter of Award](https://nsearchives.nseindia.com/corporate/GKENERGY%5F21092026130929%5FIntimation%5Fof%5FReceipt%5Fof%5Forder%5Fsd.pdf) from Maharashtra State Electricity Distribution Company for 150 MW / 300 MWh of Battery Energy Storage Systems with VGF support, at a tariff of ₹2,38,000 per MW per month; a second same-day filing repeats the announcement without new detail. - **Biocon Biologics'** Pertuzumab biosimilar received a [positive CHMP opinion](https://nsearchives.nseindia.com/corporate/BIOCON%5F21092026082614%5FPressrelease21092026.pdf) from the European Medicines Agency, recommending EU marketing authorisation for HER2-positive breast cancer; the company describes it as the first monoclonal-antibody biosimilar to clear this tailored clinical-development pathway. - **Symbiotec Pharmalab**'s investor release for Q1 FY27 [states the company serves](https://nsearchives.nseindia.com/corporate/SYMBIOTEC%5F21092026195951%5FSymbiotecInvestorReleaseQ1FY2027.pdf) over 200 customers in more than 40 countries across APIs, CDMO and complex injectables, with USFDA, EU-GMP, WHO-GMP and Japan-PMDA approvals across its Madhya Pradesh facilities. ## Regulatory **MTNL** disclosed a [TRAI order](https://nsearchives.nseindia.com/corporate/MTNL%5F21092026172518%5FSD%5FSE%5FFINE%5F21092026.pdf) dated 21 September imposing a financial disincentive of ₹14,00,000 for contravening quality-of-service regulations on its wireline access service for the quarter ended December 2025 — a small penalty, but one more entry on a company we have covered this week for ₹9,654 crore of bank-loan defaults. ## What we're not reporting **Videocon Industries** and 12 other Videocon-group companies gave prior intimation of the 65th consolidated Committee of Creditors meeting, scheduled for 23 September — a continuation of a long-running insolvency process, not new information. Two companies (Shirpur Gold Refinery, and an unnamed company under a separate CIRP) gave similar prior notice of routine CoC meetings. The remainder of the day's material MEDIUM tier was promoter-level share disclosures under SEBI's takeover and insider-trading regulations, none individually large enough to warrant a line, and a run of independent-director and KMP resignations citing personal reasons or fee non-payment, none disclosing a governance dispute beyond what was stated. --- > Educational research, not investment advice. Every figure above is drawn from the named company's own primary filing dated 21 September 2026 and checked against the source; where a filing disclosed no value, none is stated. No buy/sell recommendations, no price targets. Moat & Margin is not a SEBI-registered Research Analyst or Investment Adviser.